Malaria Vaccine, New Hope to Combat disease

Malaria Vaccine, New Hope to Combat disease

By Maina Roy Mwangi

Scientists from PATH organization have come up with a malaria vaccine to help eliminate malaria and its spread.

Kenya has become the third country in the world to roll out the vaccine with successful results being noted in Zambia.


Malaria remains a highly devastating disease that imposes great health, social and economic hardships on families across the country. Approximately 6,000 people in the country die from the disease in the country.

Controlling and eventually eliminating malaria will result in long-term benefits including the improved general health of the citizens, easing treatment burdens on hospitals and families, and enhanced economic outcomes.

Therefore, the vaccine is a great step ahead towards achieving sustainable development goals as a country. The PATH vaccine is a leader in the battle to control and eliminate malaria all over the country.

The PATH Centre for Malaria Control and Elimination leverages a unique blend of technical expertise, relationship, and ground knowledge to bring new ideas, bring together collaborators and experts, and accelerate strategies for elimination.

This work is intended to empower the national government in its goal to eliminate malaria outbreaks and transmission once and for all.

Vaccine Development

Vaccinologists pursue different approaches to developing malaria vaccines Malaria vaccine scientists evaluate different vaccine candidates and formulations that are designed to stimulate the immune system to destroy or arrest the malaria parasite.

A malaria vaccine’s desired actions can take place at several points during the life cycle of the parasite. 

The most significant challenge that malaria vaccine scientists face is a lack of understanding of the specific immune responses associated with protection against the parasitic disease.

Because the malaria parasite is so complex, scientists pursue a diversity of vaccine development approaches. Many believe that a vaccine for Malaria will need to encompass more than a single approach to reach a high degree of efficacy. 

Maina Roy is a Journalism Student at KCA University,

Hits: 434